Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
The present invention provides citrullinated 14-3-3η peptides and antibodies thereto and methods of using same to evaluate arthritic conditions such as rheumatoid arthritis.
1. A method for diagnosing Rheumatoid Arthritis in a subject comprising:
i) obtaining a biological sample from a subject suspected of having or at risk for developing Rheumatoid Arthritis,
ii) contacting said biological sample from the subject with at least one citrullinated 14-3-3 eta protein or fragment thereof comprising at least one citrullinated 14-3-3 eta epitope under a condition suitable for the formation of at least one immune complex between the citrullinated 14-3-3 eta protein or fragment thereof and autoantibodies specific for said citrullinated 14-3-3 eta epitope that may be present in the biological sample, wherein said citrullinated 14-3-3 eta epitope comprises a citrulline residue at a position selected from the group consisting of position 4, position 12, position 19, position 42, position 61, position 86 and position 227 of SEQ ID NO: 5; and
iii) detecting the presence of immune complexes between the citrullinated 14-3-3 eta protein or fragment thereof and autoantibodies that specifically bind the citrullinated 14-3-3 eta epitope of the citrullinated 14-3-3 eta protein or fragment thereof, wherein said presence of said immune complexes is indicative of Rheumatoid Arthritis in said subject.
2. The method of claim 1 , wherein said detecting step further comprises measuring the amount of autoantibodies against the citrullinated 14-3-3 eta protein or fragment thereof.
3. The method according to claim 1 , wherein the citrullinated 14-3-3 eta protein or fragment thereof is detectably labeled with a label selected from the group consisting of a radioactive label, a luminescent label, and a fluorescent label, and an enzyme.
4. The method according to claim 1 , wherein the citrullinated 14-3-3 eta protein or fragment thereof is bound to a solid support.
5. The method according to claim 1 , wherein the autoantibodies are detected by an ELISA assay.
6. The method according to claim 1 , wherein said detection occurs by chemiluminescence.